BioCentury
ARTICLE | Clinical News

BioChaperone PDGF-BB: Phase III start

March 25, 2013 7:00 AM UTC

Adocia said it received positive scientific advice from EMA for a placebo-controlled, European Phase III trial of BioChaperone PDGF-BB. The trial is slated to start mid-2014. According to Adocia, EMA ...